ALPS Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-77,328
| Closed | -$550K | – | 1050 |
|
|
2025
Q1 | $550K | Sell |
77,328
-5,030
| -6% | -$35.8K | ﹤0.01% | 578 |
|
|
2024
Q4 | $960K | Buy |
82,358
+6,147
| +8% | +$71.7K | 0.01% | 486 |
|
|
2024
Q3 | $1.57M | Buy |
76,211
+974
| +1% | +$20K | 0.01% | 395 |
|
|
2024
Q2 | $1.68M | Buy |
75,237
+7,455
| +11% | +$167K | 0.01% | 366 |
|
|
2024
Q1 | $1.86M | Buy |
67,782
+5,487
| +9% | +$151K | 0.01% | 364 |
|
|
2023
Q4 | $1.9M | Buy |
+62,295
| New | +$1.9M | 0.01% | 337 |
|
|
2022
Q4 | – | Sell |
-41,521
| Closed | -$2.32M | – | 1072 |
|
|
2022
Q3 | $2.32M | Sell |
41,521
-3,479
| -8% | -$195K | 0.02% | 284 |
|
|
2022
Q2 | $2.33M | Buy |
+45,000
| New | +$2.33M | 0.02% | 288 |
|